Biblio
Analysis of a genetic polymorphism in the costimulatory molecule TNFSF4 with HSCT outcomes. Biol Blood Marrow Transplant. 2015.
A phase 1 clinical trial of long-term, low-dose treatment of WHIM syndrome with the CXCR4 antagonist plerixafor. Blood. 2014.
WHIM Syndrome-linked CXCR4 mutations drive osteoporosis. Nat Commun. 2023;14(1):2058.